Gonyer David A 4
4 · Evoke Pharma Inc · Filed Jan 29, 2021
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+415,000→ 415,000 totalExercise: $2.68Exp: 2031-01-26→ Common Stock (415,000 underlying)
Footnotes (1)
- [F1]The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2021, subject to the reporting person's continuous service to the issuer on each such vesting date.